[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 August 22, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2010 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated June 10, 2011 regarding the]
[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 19, 2011 Division of Corporation Finance 100 F Street, NE Mail Stop: 3561 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 3, 2011 and Amended March 17,]
[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 19, 2011 Division of Corporation Finance 100 F Street, NE Mail Stop: 3561 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 3, 2011 and Amended March 17,]
[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 19, 2011 Division ofrporation Finance 100 F Street, NE Mail Stop: 3561 Attention:Jim B. Rosenberg, Seniorsistant Chief Accountant Re: China Pharmas, Form 10-K for the Fiscal Year Ended December 31, 2010]
[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 19, 2011 Division ofrporation Finance 100 F Street, NE Mail Stop: 3561 Attention:Jim B. Rosenberg, Seniorsistant Chief Accountant Re: China Pharmas, Form 10-K for the Fiscal Year Ended December 31, 2010]
[Sinovac Reports Unaudited Second Quarter 2011 Financial Results - Conference call scheduled for Friday, August 12, 2011 at 8:00 AM EDT – – Sinovac Biotech Ltd. ( today its unaudited second Beijing – August 12, 2011 Second Quarter 2011 Financial Highlights · Sales increased 52.5% year-over-year to $15.7 million, compared to $10.3 million. · Net income attributable to shareholder reached] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x ¨ Form 20-F SINOVAC BIOTECH LTD. 6-K 1 v232192_6k.htm FORM 6-K]
[Sinovac Reports Unaudited Second Quarter 2011 Financial Results - Conference call scheduled for Friday, August 12, 2011 at 8:00 AM EDT – – Sinovac Biotech Ltd. ( today its unaudited second Beijing – August 12, 2011 Second Quarter 2011 Financial Highlights · Sales increased 52.5% year-over-year to $15.7 million, compared to $10.3 million. · Net income attributable to shareholder reached] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x ¨ Form 20-F SINOVAC BIOTECH LTD. 6-K 1 v232192_6k.htm FORM 6-K]
[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]
[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]
[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 16, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division of Corporation Finance 100 F Street, NE Re: China Pharma Holdings, Inc. Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011 Form 10-Q for]
